Where does Angiomed GmbH & Co. Medizintechnik KG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Angiomed GmbH & Co. Medizintechnik KG ranks #17,439 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Angiomed GmbH & Co. Medizintechnik KG hold?

Angiomed GmbH & Co. Medizintechnik KG holds 16 US utility patents granted between 2016 and 2025, spanning 7 technology areas.

What is Angiomed GmbH & Co. Medizintechnik KG's Innovation Score?

Angiomed GmbH & Co. Medizintechnik KG has an Innovation Score of 29.8 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Angiomed GmbH & Co. Medizintechnik KG's patent grant rate increasing or decreasing?

Angiomed GmbH & Co. Medizintechnik KG's recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Angiomed GmbH & Co. Medizintechnik KG's patents?

Angiomed GmbH & Co. Medizintechnik KG's patents average 13.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Angiomed GmbH & Co. Medizintechnik KG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Angiomed GmbH & Co. Medizintechnik KG

Q: What technology areas does Angiomed GmbH & Co. Medizintechnik KG focus on?

Angiomed GmbH & Co. Medizintechnik KG's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 14 patents, ranking #463 of 3,082 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Angiomed ranks #17,439 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 7 technology areas.

#17,439
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.8/100): 13.0
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17439 · Foreign Corporation #17,439 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,439/49,997
PHOTO-FINISH Ammeraal Beltech…
CPC-NARROW A61F · 7 areas
INNOV-THIN 29.8/100
CLAIMS-RICH 13.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ammeraal Beltech Modular A/S (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Angiomed’s 29.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (33%) Velocity 2.9 pts (10%) Breadth 9.4 pts (31%) Claim depth 7.8 pts (26%)

Qualcomm Incorporated · highest

85
Angiomed & Medizinte… · this assignee

30
3D Lighting… · lowest

7

What this shows Angiomed's Innovation Score is 29.8/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Angiomed?

Each dot is one of Angiomed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Angiomed’s own 13.0 claims/patent is ABOVE the 12.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Angiomed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Angiomed's grants concentrate

Angiomed GmbH & Co. Medizintechnik KG is a focused PatentsView assignee: 7 CPC subclasses with 87.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2017. By volume, Angiomed sits between Ammeraal Beltech Modular A/S and AquaBeam, LLC.

Angiomed's three-year grant acceleration

Angiomed GmbH & Co. Medizintechnik KG shows 3 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ammeraal Beltech…

16
Amunix Operating

16
Anaren

16
Andon Health

16
Angion Biomedica

16
Apicore US

16
Aqua-aerobic Syst…

16
Aquabeam

16
Angiomed & Medizi… ◀

16

What this shows Angiomed holds 16 patents at rank #17,455, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Angiomed

By rank, the assignees closest to #17,455 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Angiomed's primary technology class.

Angiomed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Angiomed GmbH & Co. Medizintechnik KG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	18.8%
2017	1	6.3%
2018	1	6.3%
2019	4	25.0%
2020	2	12.5%
2021	1	6.3%
2023	1	6.3%
2024	2	12.5%
2025partial year	1	6.3%

Which technologies does Angiomed GmbH & Co. Medizintechnik KG patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 14

A61B - DIAGNOSIS; SURGERY; Identification 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

Y10T - Technical Subjects Covered BY Former US Classification 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

B26F - PERFORATING; PUNCHING; CUTTING-OUT; STAMPING-OUT; Severing BY Means Other Than Cutting 1

B23K - Soldering OR UNSOLDERING; WELDING; Cladding OR Plating BY Soldering OR WELDING; Cutting BY Applying Heat Locally, e.g. Flame CUTTING; Working BY Laser Beam 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Angiomed GmbH & Co. Medizintechnik KG's patent record in context - here's where to go next.

Angiomed GmbH & Co. Medizintechnik KG's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 87.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #17,439 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Angiomed GmbH & Co. Medizintechnik KG against Ammeraal Beltech Modular A/S, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.